Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Tobacco Induced Diseases
Metadata
Title
Awareness and attitude to the law banning smoking in public places in Osun State, Nigeria
Publication date
01-12-2014
Published in
Tobacco Induced Diseases / Issue 1/2014
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-12-6

Other articles of this Issue 1/2014

Tobacco Induced Diseases 1/2014 Go to the issue

Research

Effectiveness of proactive and reactive services at the Swedish National Tobacco Quitline in a randomized trial

Short report

A pilot study of research methods for determining the impact of pictorial cigarette warning labels among smokers

Research

Factors determining intention to quit tobacco: exploring patient responses visiting public health facilities in India

Research

Tobacco retail availability and smoking behaviours among patients seeking treatment at a nicotine dependence treatment clinic

Research

Lower expressions of the human bitter taste receptor TAS2R in smokers: reverse transcriptase-polymerase chain reaction analysis

Research

The association between senior student tobacco use rate at school and alternative tobacco product use among junior students in Canadian secondary schools

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits